BACKGROUND
Medical device developers can often be limited in preclinical experimental testing of new products because of procedural complexities and safety concerns to the animal or patient. Though animal or human cadavers can be used for these types of studies thereby eliminating the need for safety precautions, the functional capabilities of the tissue can be lost. As a novel way to provide such functional device/tissue assessment, the Visible Heart ® (VH ® ) Laboratory has developed reanimation methodologies 1 that allow the four chambers of the heart to contract naturally ex vivo. Swine hearts are routinely reanimated using this methodology with a clear perfusate which allows for direct endoscopic visualization of functional cardiac anatomy and importantly the device/tissue interface. For the past two decades, these capabilities have been useful for testing early device prototypes and developing educational and procedural videos. More specifically, this approach provides the added convenience of manipulating catheters into the ex vivo prep and visually studying their behavior for validation experiments of new medical devices. Further, multimodal imaging comparative assessments using both 4D echocardiography and fluoroscopy have been routinely performed. Yet, as imaging modalities continue to develop and are utilized for device placements or post-procedure evaluations, we hope to expand VH ® capabilities.
Here we describe the ability to utilize VH ® methodologies to include cardiac device testing during computed tomography (CT) scanning. These capabilities should provide design engineers with more information as to how their devices interact with functional tissues within the 3D contractile environment. These investigations can utilize CT imaging with high volume contrast injections, high radiation dosages (increased tube voltage and decreased tube current) 2 , and high-phase information. These parameters are difficult to achieve in living animals or patients because of the safety considerations, but have and will be easily justified for applications in these described VH ® studies. The VH ® system our research team routinely uses is not portable and thus could not be easily used within a CT scanner. Therefore, in order to expand the VH ® Laboratories research capabilities to include CT imaging of reanimated large mammalian hearts, a Visible Heart ® Mobile (VH ® M) was created. As described here, the mobile system allows for the transport of the heart from the VH ® labroatory (where the organ can be explanted and cannulated) to the CT scanner as well as the continuous perfusion in a functional state during scanning. 
METHODS
The developed VH ® M system allows for the clear perfusate to be pumped to two reservoirs that feed buffer into the right and left sides of the heart through the cannulated inferior vena cava and pulmonary veins, respectively. The outflow from the cannulated pulmonary artery and the aorta return fluid to a common reservoir ( Figure 2 ). The common reservoir is automatically refilled using multiple level sensors and an electrical controller. The right, left, and common reservoirs as well as the pumps sit on the multilevel rolling cart. The ability to switch between retrograde Langendorf perfusion to a four chamber working mode is also implemented into the system. The beating heart sits in a clear box with holes drilled for fixation of the inflow and outflow tubes (Figure 3) . The drain and heart tray are supported by a second multilevel rolling cart. Long tubing connects these carts and is typically manually supported during transport. Additional access cannula ports are incorporated for the placement of video scopes or cardiac devices while the heart is functioning on the VH ® M system. On a weekly basis, our team utilizes excised swine hearts for VH ® investigations. Afterward, these same hearts can be placed on the VH ® M system and transported to the nearby clinical CT imaging facility. During transport, the heart can remain beating or be stopped with cardioplegia (requiring a defibrillatory shock to resume intrinsic function). The specimen can be either contracting in a native sinus rhythm or paced with a desired pacing system and is then imaged with full cardiac spiral CT scans (Figure 4 ). Contrast can be power injected through incorporated drug ports or placed via catheters within various vessels or chambers, such as clinically placed angiogram or venogram catheters. Further, multi-phase scans can be performed through time delays or gating via electrocardiograms collected through electrodes placed on the supporting structures. Devices can be implanted between scans using the portable endoscopic cameras. 
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B Figure 2. A) Schematic and B) Image of VH ® M apparatus. The right and left circuits run simultaneously. Perfusate is recycled through the system or drained into a common drain. Contrast can be injected into various vessels or chambers using catheters or incorporated ports.
RESULTS
A portable VH ® M apparatus was assembled and utilized for preliminary studies. Functional swine hearts have been moved from the VH ® to the VH ® M and transported to the CT scanner. To date, images have been obtained both after injection of contrast into the whole system and after injection directly into the inferior vena cava and pulmonary vein inflows. Samples of reconstructed multi-phase images of an edematous swine heart can be seen in Figure 5 . Figure 6 shows 3D digital renderings of angiograms from a swine heart imaged with multi-phase CT. Using these images, device designers can have a better understanding of the 3D motion of the heart as well as device/tissue interactions over a cardiac cycle. 
INTERPRETATION
This study reports the novel (preliminary) results of our laboratories developed methodology for utilizing an ex vivo heart perfused with a clear perfusate and functioning within a CT scanner. Importantly, the ability to image reanimated hearts (human or animal) with no concerns relative to animal or patient safety allows for the use of high volume contrast injections and high radiation dosages, both which greatly increase the quality of the obtained CT image. Additionally, the multi-phase information is considered particularly valuable for device designers studying how the new product interacts with a functional heart in 3D space throughout the cardiac cycle. Combining the benefits of the CT imaging with the ability to have internal functional imaging as in the VH ® will likely provide device designers even more information relative to critical device/tissue interactions. This ultimately will allow for more thoroughly tested devices and more detailed computational models.
Future goals of this VH ® M project are to functionally image different cardiac devices (including Medtronic's Micra Leadless Pacemaker and Transcatheter Aortic Valves) at high resolutions and with multi-phase scanning. Subsequently, reconstructed scans can be modeled at each phase throughout the cardiac cycle. Constructed models can be cycled through in the VH ® Lab's virtual reality system which will show 3D device motion throughout the complete cardiac cycle. Perhaps the system can be further adapted to be suitable for an MRI. Additionally, the VH ® Lab has the opportunity to receive human hearts that are not viable for transplant, hence it is envisioned that our laboratory in the near future will have the privilege to utilize the VH ® M system to reanimate human hearts while performing high resolution CT scans. This unique opportunity will provide students of anatomy, clinicians, as well as device designers even more novel insights as to human heart functional anatomies, multimodal imaging assessments, and device/tissue interactions.
